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Introduction
Castleman’s Disease (CD) is a rare benign lymphoprolifera-
tive disorder involving hyperplasia of lymph tissue in 2 dis-
tinct disease patterns—unicentric or multicentric. Histolog-
ically, 3 variants are described: hyaline vascular, plasmacytic, 
or with mixed cellularity.1 Unicentric disease commonly 
presents as an asymptomatic mass in proximity to the tra-
cheobronchial tree or hilum. Posterior mediastinal involve-
ment is exceedingly rare,2 as is CD complicated by vascular 
malformation. We present a case of CD with vascular mal-
formation in the posterior mediastinum of a 26-year-old 
symptomatic female.
Case presentation
A 26-year-old female with a small goitre was referred to 
our hospital for evaluation after experiencing 9 months of 
a dull aching pain in her left chest and flank associated with 
tingling in the same areas and weight loss. She denied any 
history of treatment for tuberculosis. The physical exam was 
unremarkable apart from the 2 × 2 cm benign goitre. Chest 
x-ray revealed a posterior mediastinal opacity. Computerized 
tomography (CT) of the thorax demonstrated a 10 × 6 cm, 
well-defined, hyperenhancing posterior mediastinal mass 
(Figure 1). A preliminary radiographic diagnosis of poste-
rior mediastinal neurogenic tumour was made. Abdominal 
ultrasound and CT of the 
abdomen revealed no per-
tinent findings. 
The patient underwent 
a right posterolateral tho-
racotomy. Intraoperatively, 
a highly vascular posterior 
para-oesophageal mediasti-
nal mass was encountered. 
The mass was covered by 
mediastinal pleura, which 
was excised separately. The 
mass was not adherent to 
any mediastinal structure, 
Abstract
Castelman’s disease (CD) is a rare lymphoproliferative disorder of unknown aetiology, with the unicentric form usually involving 
the chest. Posterior mediastinal involvement is uncommon, exceedingly so when associated with vascular malformation. We 
report the case of a young female patient who presented with 9 months of left-sided, dull chest and flank pain associated with 
weight loss and a subjective tingling sensation. Imaging reveled a well-circumscribed hyper-enhancing posterior mediastinal pa-
ra-oesophageal mass. She underwent a right posterolateral thoracotomy, mass excision. Histopathologic examination confirmed 
Castleman’s disease (CD) with arteriovenous malformation.
CD with vascular malformation is a very rare condition that can only be diagnosed histopathologically. Surgical resection is effec-
tive and has a good prognosis.
Keywords: Castleman’s disease, AV malformation, posterior mediastinum
© 2018 A.T. Tamire. This open access article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were made. 
East Cent Afr J Surg. 2018 Aug;23(2):76–79
https://dx.doi.org/10.4314/ecajs.v23i2.5
Figure 1. CT thorax before (a) and after (b) administrating of contrast medium demonstrating a 
well-defined 10x6 cm hy-per enhancing para-esophageal mass.
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and it was enucleated, appearing smaller than the radio-
graphic evidence suggested. Gross pathologic examination 
of the tumour revealed a tan-coloured, lobular, well-circum-
scribed mass (Figure 2). Thin sections under microscopy 
demonstrated hypervascular follicular hyperplasia (Figure 
3a) and a hamartomatous vascular lesion with features of an 
arteriovenous (AV) malformation.
Discussion
CD was originally described by Benjamin Castleman in 
a 1954 case report3 and a 1956 case series.4 CD is a benign 
disease of the lymph nodes with characteristic nonclonal 
hyperplasia of the follicles. The condition is also referred to 
as benign giant lymphoma, angiofollicular lymph node hy-
perplasia, follicular lymphoreticuloma, lymphoid hamarto-
ma, and giant cell lymph node hyperplasia. The rarity of the 
condition makes understanding of its epidemiology and pre-
cise aetiology difficult with all available information coming 
from case reports, case series, and expert opinions. 
The incidence of CD is unknown, but there were more 
than 400 cases reported in the international literature as of 
2001.5 CD affects males and females equally, and it is most 
commonly seen in the third decade of life; the plasmacytic 
type usually affects people in their sixth decade.
The majority of unicen-
tric CD is located in the 
mediastinum (70%) with 
posterior mediastinal CD 
being extremely rare.6–8 
Review of the available lit-
erature revealed 10 cases of 
CD, primarily arising from 
the posterior mediastinum, 
that were diagnosed as neu-
rogenic tumours, much like 
our case. The presentation 
of our patient with pain and 
tingling increased our pre-
operative suspicion of a tu-
mour of neurogenic origin. 
To date, only 1 case se-
ries and 1 case report of CD 
discuss a vascular neoplasm 
complicating the disease. 
Gerald et. al. reported the 
development of vascular 
neoplasia in 7 cases of CD 
in 1990, with 1 being medi-
astinal. The authors postu-
lated that angiogenic factor 
produced by the activated 
lymphoid tissue might con-
tribute to the development 
of the vascular neoplasia.9 
The case report by Chan et 
al. in 1994 discussed a case 
with a follicular dendritic 
cell tumour and vascular 
neoplasm complicating intra-abdominal (mesocolon) CD.10 
Hence, our case marks the ninth case of CD complicated by 
vascular neoplasm and only the second of mediastinal CD 
with vascular neoplasia.
There has been only 1 reported case of posterior medias-
tinal CD with a hypervascular tumour, which presented as 
a hypervascular lipomatous posterior mediastinal mass. The 
authors postulated the hypervascularity to be reactive in na-
ture, with pathology demonstrating the typical hyaline vas-
cular type of CD with no associated vascular lesion.11 Unique 
to our case, there was a component of hamartomatous vas-
cular neoplasia (AV malformation) identified in addition to 
the hyaline vascular type of CD found on histology. 
Clinically, CD is classified into 2 major types. The more 
common unicentric CD (two-thirds of cases) usually in-
volves single lymph node stations of the mediastinum, ab-
domen, neck, or axilla. Multicentric CD involves multiple 
lymph nodes and other lymphoid structures, carrying a 
poorer overall prognosis than unicentric CD. The precise 
cause of CD is unknown; however, the multicentric disease is 
associated with human herpesvirus 8 (Kaposi’s sarcoma-as-
sociated herpes virus), found most commonly in HIV-in-
fected individuals.12 Interleukin-6 (IL-6) is also described as 
Figure 2. Gross appearance of the tumor, (a) lobular well circumscribed mas, (b) with central 
hemorrhage
Figure 3. Angiofollicular hyperplasia (Castleman’s Disease) of para-oesophageal lymph 
node (a) associat-ed with a hamartomatous vascular lesion (AV malformation) (b)
a b
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an important factor in the pathogenesis of this disease.13–16 
Multicentric disease has been associated with POEMS (poly-
neuropathy, organomegaly, endocrinopathy, monoclonal 
gammopathy, and skin changes) syndrome.
Histologically, CD is classified into 3 variants: hyaline 
vascular, plasmacytic, and mixed cellularity.1 The hyaline 
vascular variety is the predominant type identified in uni-
centric CD, and the plasmacytic histology is found in most 
cases of multicentric CD.1
The clinical manifestations are protean. CD has great 
variation in presenting signs and symptoms, determined by 
the extent of the disease, type of pathology, HIV status, ex-
tent of IL-6 secretion, associated autoimmune phenomena, 
and overlap with POEMS syndrome.13 Unicentric disease 
can present incidentally or as a mass with local symptoms 
due to mass effect. Multicentric CD can present with en-
largement of multiple lymph nodes throughout the body, 
hepatosplenomegaly, and systemic symptoms like fever, 
night sweats, weight loss and anorexia. Such cases can have 
derangements in a wide range of biochemical studies, in-
cluding anaemia, elevated erythrocyte sedimentation rate, 
C-reactive protein, and organ function tests.
Diagnosis requires a tissue sample, often obtained via 
excisional biopsy, as small samples of isolated cells from a 
fine-needle aspiration may lead to diagnosis failure.1
There are no published randomized clinical trials that 
address CD management. Most of the literature is confined 
to small series or case reports, and it is difficult to make firm 
recommendations.17 Clinical staging guides treatment deci-
sions and prognosis. The goals of the staging and pretreat-
ment evaluation are to (a) determine whether the patient has 
unicentric or multicentric disease, (b) identify patients with 
systemic inflammatory manifestations of the disease, and (c) 
assess for the presence of HIV, as well as associated condi-
tions and malignancies.
Complete surgical resection is 95% curative with unicen-
tric CD and affords resolution of constitutional symptoms, 
if present. Whenever surgical resection is not feasible, radi-
ation therapy is an acceptable alternative.7,13,17,18 Recurrenc-
es can occur in cases treated with incomplete resection for 
unicentric CD as late as 11 years later; therefore, long-term 
follow-up is warranted.7,19 Most of the publications regard-
ing unicentric CD treated with complete surgical resection 
reported no recurrence. In our case, given the complete 
enucleation of the tumour and the histopathology findings 
lacking any adverse prognostic factors, we are fairly certain 
that our patient has an excellent prognosis with long-term 
follow-up.20
Treatment of multicentric CD is more complicated, rang-
ing from multimodal approaches involving surgery and che-
motherapy to targeted administration of monoclonal anti-
bodies and steroids. Without any randomized studies, these 
treatment recommendations are based on limited case stud-
ies and case series.
Conclusions
CD is a rare benign lymphoproliferative condition and 
should be considered as a diagnosisfor for patients with 
benign lymphadenopathies. We have presented here a very 
rare disease in an unusual location, which mimicked a  neu-
rogenic tumour and was further complicated by a vascular 
malformation. Management relies up on determining the 
histologic and anatomic types of the disease and identifica-
tion of associated pathologies, such as  HIV. Unicentric CD 
has an excellent prognosis with complete excision, which 
was achieved in our patient.
Acknowledgements
I would like to acknowledge Prof. Schneider for the histo-
logical examination and accompanying photographs. 
Competing interests
The author declares that he has no competing interests 
related to this work.
References
1. Roca B. Castleman’s disease. A review. 
AIDS Rev. 2009 Jan-Mar;11(1):3-7.
2. Ko SF, Wan YL, Ng SH, Lin JW, Hsieh 
MJ, Fang FM, et al. Imaging features of 
atypical thoracic Castleman disease. Clin 
Imaging. 2004 Jul-Aug;28(4):280-5. doi: 
10.1016/S0899-7071(03)00202-X.
3. Castleman B, Towne VW. Case records 
of the Massachusetts General Hospital; 
weekly clinicopathological exercises; 
founded by Richard C. Cabot. Case 40351. 
N Engl J Med. 1954 Sep 2;251(10):396-400. 
doi: 10.1056/NEJM195409022511008.
4. Castleman B, Iverson L, Menendez 
VP. Localized mediastinal lymphnode 
hyperplasia resembling thymoma. 
Cancer. 1956 Jul-Aug;9(4):822-30. doi: 
10.1002/1097-0142(195607/08)9:4<822::AID-
CNCR2820090430>3.0.CO;2-4.
5. Sarrot-Reynauld F. Castleman’s disease 
[Internet]. In: Orphanet encyclopedia. 
Paris: Orphanet; c2001. Available from: 
https://www.orpha.net/data/patho/Pro/
en/Castleman-FRenPro3618.pdf.
6. Keller AR, Hochholzer L, Castleman B. 
Hyaline-vascular and plasma-cell types 
of giant lymph node hyperplasia of 
the mediastinum and other locations. 
Cancer. 1972 Mar;29(3):670-83. doi: 
10.1002/1097-0142(197203)29:3<670::AID-
CNCR2820290321>3.0.CO;2-#
7. Iyoda A, Yusa T, Hiroshima K, Fujisawa 
T, Ohwada H. Castleman’s disease in 
the posterior mediastinum: report of a 
case. Surg Today. 2000;30(5):473-6. doi: 
10.1007/s005950050629.
8. Eisenstat RS, Price DB, Rosenthal 
AD, Schuss AL, Katz DS. Thoracic 
epidural Castleman’s disease. AJR Am J 
Roentgenol. 2002 Jan;178(1):208-10. doi: 
10.2214/ajr.178.1.1780208.
9. Michaelides M, Nikolaidou A, 
Konstantinou D, Balis G, Tsitouridis I. 
Posterior mediastinal Castleman’s disease 
presented as hypervascular lipomatous 
tumor. Hippokratia. 2011 Oct;15(4):361-2.
10. Gerald W, Kostianovsky M, Rosai J. 
Development of vascular neoplasia 
in Castleman’s disease. Report of 
seven cases. Am J Surg Pathol. 1990 
Jul;14(7):603-14.
EAST and CENTRAL AFRICAN Journal of Surgery | VOLUME 23 | NUMBER 2 | AUGUST 2018 79journal.cosecsa.org
Posterior mediastinal Castleman’s disease
Case Report
11. Stebbing J, Pantanowitz L, Dayyani F, 
Sullivan R, Bower M, Dezube BJ. HIV-
associated multicentric Castleman’s 
disease. Am J Hematol. 2008 
Jun;83(6):498-503. doi: 10.1002/ajh.21137.
12. Chan JK, Tsang WY, Ng CS. Follicular 
dendritic cell tumor and vascular 
neoplasm complicating hyaline-vascular 
Castleman’s disease. Am J Surg Pathol. 
1994 May;18(5):517-25.
13. Chang Y, Cesarman E, Pessin MS, 
Lee F, Culpepper J, Knowles DM, et 
al. Identification of herpesvirus-like 
DNA sequences in AIDS-associated 
Kaposi’s sarcoma. Science. 1994 Dec 
16;266(5192):1865-9. doi: 10.1126/
science.7997879.
14. Soulier J, Grollet L, Oksenhendler E, 
Cacoub P, Cazals-Hatem D, Babinet P, et al. 
Kaposi’s sarcoma-associated herpesvirus-
like DNA sequences in multicentric 
Castleman’s disease. Blood. 1995 Aug 
15;86(4):1276-80.
15. An J, Lichtenstein AK, Brent G, Rettig 
MB. The Kaposi sarcoma-associated 
herpesvirus (KSHV) induces cellular 
interleukin 6 expression: role of the KSHV 
latency-associated nuclear antigen and 
the AP1 response element. Blood. 2002 
Jan 15;99(2):649-54. doi: 10.1182/blood.
V99.2.649. 
16. Chronowski GM, Ha CS, Wilder RB, 
Cabanillas F, Manning J, Cox JD. Treatment 
of unicentric and multicentric Castleman 
disease and the role of radiotherapy. 
Cancer. 2001 Aug 1;92(3):670-6. doi: 
10.1002/1097-0142(20010801)92:3<670::AID-
CNCR1369>3.0.CO;2-Q.
17. van Rhee F, Stone K, Szmania S, Barlogie 
B, Singh Z. Castleman disease in the 
21st century: an update on diagnosis, 
assessment, and therapy. Clin Adv 
Hematol Oncol. 2010 Jul;8(7):486-98.
18. Safford SD, Lagoo AS, Mahaffey SA. 
Preoperative embolization as an adjunct 
to the operative management of 
mediastinal Castleman disease. J Pediatr 
Surg. 2003 Sep;38(9):E21-3. doi: doi.
org/10.1016/S0022-3468(03)00421-4.
19. Olscamp G, Weisbrod G, Sanders D, 
Delarue N, Mustard R. Castleman disease: 
unusual manifestations of an unusual 
disorder. Radiology. 1980 Apr;135(1):43-8. 
doi: 10.1148/radiology.135.1.7360978.
20. Talat N, Belgaumkar AP, Schulte KM. 
Surgery in Castleman’s disease: a 
systematic review of 404 published cases. 
Ann Surg. 2012 Apr;255(4):677-84. doi: 
10.1097/SLA.0b013e318249dcdc.
